===Hims & Hers Health (HIMS) reported earnings on Mon 7 Nov 22 (a/h)

 

Hims & Hers Health beats by $0.01, beats on revs; guides Q4 revs above consensus 

• Reports Q3 (Sep) loss of $0.09 per share, excluding non-recurring items, $0.01 better than the S&P Capital IQ Consensus of ($0.10); revenues rose 95.3% year/year to $144.84 mln vs the $130.33 mln S&P Capital IQ Consensus.
• Co issues upside guidance for Q4, sees Q4 revs of $159-$162 mln vs. $134.24 mln S&P Capital IQ Consensus.